Is Solasia Pharma KK halal to invest in?

As of July 2026, Solasia Pharma KK 9SO.SG is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Solasia Pharma KK a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Solasia Pharma KK using these criteria to determine its compliance status.

Can Muslims buy shares of Solasia Pharma KK?

Muslim investors may consider investing in Solasia Pharma KK if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Solasia Pharma KK classified as NOT COVERED?

Musaffa determines the Shariah status of Solasia Pharma KK by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Solasia Pharma KK updated?

The Shariah compliance status of Solasia Pharma KK may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Solasia Pharma KK become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Solasia Pharma KK?

You can check the latest Shariah compliance status of Solasia Pharma KK on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Solasia Pharma KK 9SO.SG

Last Updated: Jul 17, 12:00 AM·XSTU

Solasia Pharma KK. Stock Analysis 9SO.SG

Germany Health Care Nano Cap

Solasia Pharma KK engages in the development, sale, import and export of pharmaceutical products and medical devices. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 22 full-time employees. The company went IPO on 2017-03-24. Its main business area is the development and sale of pharmaceuticals for the treatment of malignant tumors. The company also develops and sells pharmaceuticals and medical devices that are expected to reduce adverse events caused by the administration of malignant tumor treatment drugs and radiation therapy, and improve the treatment of malignant tumors and the quality of life (QOL) of patients. The company is engaged in in-licensing of rights for pharmaceutical or medical device candidate substances, development of pharmaceutical candidates, and monetization of pharmaceutical candidates. Its development pipeline includes the transdermal granisetron preparation Sancuso, the organic arsenic preparation darinaparsin, the oral wound dressing protective material episil, and the intracellular superoxide remover PledOx.

Key Statistics of Solasia Pharma KK (9SO.SG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.12€0.14

Today's Open

€0.13

Volume

2500.00

P/E Ratio (TTM)

Financial Metrics & Statements of Solasia Pharma KK (9SO.SG)

Super Investors Invested in Solasia Pharma KK (9SO.SG)

FAQ's for Solasia Pharma KK (9SO.SG)

As of July 2026, Solasia Pharma KK 9SO.SG is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Solasia Pharma KK using these criteria to determine its compliance status.
Muslim investors may consider investing in Solasia Pharma KK if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Solasia Pharma KK by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Solasia Pharma KK may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Solasia Pharma KK on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.